198
Views
41
CrossRef citations to date
0
Altmetric
Drug Evaluation

Management of symptons associated with advanced cancer: olanzapine and mirtazapine

, , &
Pages 365-376 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maurizio Bossola, Fabio Pacelli & Giovan Battista Doglietto. (2008) Cancer cachexia: drugs in the patent literature. Expert Opinion on Therapeutic Patents 18:7, pages 739-757.
Read now
R. Freynhagen, U. Muth-Selbach, P. Lipfert, M. F. Stevens, K. Zacharowski, T. R. Tölle & H.‐J. von Giesen. (2006) The effect of mirtazapine in patients with chronic pain and concomitant depression. Current Medical Research and Opinion 22:2, pages 257-264.
Read now

Articles from other publishers (39)

Oscar Fraile-Martinez, Miguel A. Alvarez-Mon, Cielo Garcia-Montero, Leonel Pekarek, Luis G. Guijarro, Guillermo Lahera, Miguel A. Saez, Jorge Monserrat, Domitila Motogo, Javier Quintero, Melchor Alvarez-Mon & Miguel A. Ortega. (2022) Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine. Frontiers in Oncology 12.
Crossref
Orly LavanOrit PeledMeital Avishai-NeumannAbraham WeizmanAnat YahelAlan ApterAvi ValevskiSilvana FennigJerry SteinNoa Benaroya-Milshtein. (2022) Psychopharmacology in the Pediatric Oncology and Bone Marrow Transplant Units: Antidepressant Treatment. Journal of Child and Adolescent Psychopharmacology 32:3, pages 153-161.
Crossref
Guillaume Economos, Natasha Lovell, Anna Johnston & Irene J. Higginson. (2019) What is the evidence for mirtazapine in treating cancer-related symptomatology? A systematic review. Supportive Care in Cancer 28:4, pages 1597-1606.
Crossref
Kelly L. WuAmanda K. LorenzKelly J. ChristensenMolly A. FeelyElise C. CareyJacob J. Strand. (2019) Resurgence of Eating Disorders with Olanzapine. Journal of Palliative Medicine 22:2, pages 231-233.
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2019. Psychische Erkrankungen. Psychische Erkrankungen 363 444.e8 .
Eva Katharina Masel & Herbert Hans Watzke. (2017) Palliativmedizin: Grundlagen und Symptommanagement. Wiener klinische Wochenschrift Education 12:1-4, pages 49-62.
Crossref
Todd W. Mattox. (2017) Cancer Cachexia: Cause, Diagnosis, and Treatment. Nutrition in Clinical Practice 32:5, pages 599-606.
Crossref
Bart A. A. Franx, Ilse A. C. Arnoldussen, Amanda J. Kiliaan & Deborah R. Gustafson. (2017) Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy. Drugs & Aging 34:6, pages 425-436.
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2015. Psychische Erkrankungen. Psychische Erkrankungen 413 498 .
. (2013) Multiple factors must be considered when selecting the best antidepressant to treat depression in patients with cancer. Drugs & Therapy Perspectives 30:2, pages 55-59.
Crossref
Riccardo G. V. Torta & Valentina Ieraci. (2013) Pharmacological Management of Depression in Patients with Cancer: Practical Considerations. Drugs 73:11, pages 1131-1145.
Crossref
Mohammad-Reza Rouini, Hoda Lavasani, Behjat Sheikholeslami, Vahid Nikoui, Azam Bakhtiarian, Micaela Sgorbini & Mario Giorgi. (2013) Pharmacokinetics of Mirtazapine and Its Main Metabolites after Single Oral Administration in Fasting/Fed Horses. Journal of Equine Veterinary Science 33:6, pages 410-414.
Crossref
Siri Brelin, Jon Håvard Loge, Svetlana Skurtveit, Tom Børge Johannesen, Nina Aass, Stig Ottesen & Marianne Jensen Hjermstad. (2013) Antidepressants to cancer patients during the last year of life-a population-based study. Psycho-Oncology 22:3, pages 506-514.
Crossref
Angèle Ryan. 2013. Essentials of Palliative Care. Essentials of Palliative Care 229 252 .
Hee-Ju Kim, Andrea M. Barsevick, Carolyn Y. Fang & Christine Miaskowski. (2012) Common Biological Pathways Underlying the Psychoneurological Symptom Cluster in Cancer Patients. Cancer Nursing 35:6, pages E1-E20.
Crossref
Keisuke Kaneishi, Masahiro Kawabata & Tatsuya Morita. (2012) Olanzapine for the Relief of Nausea in Patients With Advanced Cancer and Incomplete Bowel Obstruction. Journal of Pain and Symptom Management 44:4, pages 604-607.
Crossref
Ricardo Millán-González. (2012) Consentimientos informados y aprobación por parte de los comités de ética en los estudios de antipsicóticos atípicos para el manejo del delírium. Revista Colombiana de Psiquiatría 41:1, pages 150-164.
Crossref
Hiroaki Shibahara, Yumiko Tokura, Tetsuya Isero, Toshiki Etani, Yousuke Ikegami, Hiroyuki Kamiya, Yoshihiro Hashimoto, Yutaka Iwase, Natsuko Uematsu, Eri Imai & Daisaku Nishimura. (2012) Mirtazapine provided remarkable relief for refractory nausea and vomiting by sunitinib and oxycodone in a patient with renal cancer. Palliative Care Research 7:1, pages 514-517.
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2012. Psychische Erkrankungen. Psychische Erkrankungen 421 512 .
Hiroaki SHIBAHARA, Yousuke MURASE, Natsuko UEMATSU, Ayako YAMAMOTO & Daisaku NISHIMURA. (2011) Low-Dose Mirtazapine Effecting the Remarkable Improvement of Nausea in a Patient with Primary Hepatocellular Carcinoma: A Case Report. JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE 60:2, pages 109-113.
Crossref
Rachel P. RiechelmannDebika Burman, Ian F. Tannock, Gary Rodin & Camilla Zimmermann. (2009) Phase II Trial of Mirtazapine for Cancer-Related Cachexia and Anorexia. American Journal of Hospice and Palliative Medicine® 27:2, pages 106-110.
Crossref
Mihail F Zilbermint & Adrian S Dobs. (2009) Nonsteroidal selective androgen receptor modulator Ostarine ™ in cancer cachexia . Future Oncology 5:8, pages 1211-1220.
Crossref
Mathias Berger, Dietrich van Calker, Eva-Lotta Brakemeier & Elisabeth Schramm. 2009. Psychische Erkrankungen. Psychische Erkrankungen 491 592 .
Dilara Seyidova Khoshknabi. 2009. Palliative Medicine. Palliative Medicine 965 972 .
Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Young-Chul Kim, Kyu-Sik Kim, Ki-Min Kim, Su-Jin Yang & Jin-Sang Yoon. (2008) Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry and Clinical Neurosciences 62:1, pages 75-83.
Crossref
Mukaila A Raji, Patrice Duhon Barnum, Jean Freeman & Avi B Markowitz. (2016) Mirtazapine for Depression and Comorbidities in Older Patients with Cancer. Annals of Pharmacotherapy 41:9, pages 1548-1549.
Crossref
R.E. KAST & K.F. FOLEY. (2007) Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects. European Journal of Cancer Care 16:4, pages 351-354.
Crossref
A. DOUZENIS, I. MICHOPOULOS, T. ECONOMOPOULOS, L. LYKOURAS & C.R. SOLDATOS. (2007) Sublingual use of olanzapine in combination with alprazolam to treat agitation in a terminally ill patient receiving parenteral nutrition. European Journal of Cancer Care 16:3, pages 289-290.
Crossref
O.M. Ahmed, R.G. Ahmed, M.M.S. Nada & M. Bahgat .. (2007) Does the Heat Stress Affect the Neurons Development in Some Central Nervous System Regions of Albino Rat Newborns?. Asian Journal of Animal and Veterinary Advances 2:3, pages 86-103.
Crossref
Egidio Del FabbroShantan G. ReddyPaul WalkerEduardo Bruera. (2007) Palliative Sedation: When the Family and Consulting Service See No Alternative. Journal of Palliative Medicine 10:2, pages 488-492.
Crossref
Luis San & Belen Arranz. (2014) Mirtazapine: only for depression?. Acta Neuropsychiatrica 18:3-4, pages 130-143.
Crossref
Elizabeth A. KvaleJohn L. Shuster. (2006) Sleep Disturbance in Supportive Care of Cancer: A Review. Journal of Palliative Medicine 9:2, pages 437-450.
Crossref
Egidio Del FabbroShalini DalalEduardo Bruera. (2006) Symptom Control in Palliative Care—Part II: Cachexia/Anorexia and Fatigue. Journal of Palliative Medicine 9:2, pages 409-421.
Crossref
Junko Adachi, Risa Kudo, Migiwa Asano, Yasuhiro Ueno, Ross Hunter, Rajkumar Rajendram, Colin Martin & Victor R. Preedy. (2006) Skeletal muscle and liver oxysterols during fasting and alcohol exposure. Metabolism 55:1, pages 119-127.
Crossref
M. Pasquini, M. Biondi, A. Costantini, F. Cairoli, G. Ferrarese, A. Picardi & C. Sternberg. (2006) Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division. Depression and Anxiety 23:7, pages 441-448.
Crossref
Todd W. Mattox. (2017) Treatment of Unintentional Weight Loss in Patients With Cancer. Nutrition in Clinical Practice 20:4, pages 400-410.
Crossref
Mukaila A Raji. (2005) Management of chemotherapy-induced side-effects. The Lancet Oncology 6:6, pages 357.
Crossref
Mellar P. Davis. 2005. Squamous Cell Head and Neck Cancer. Squamous Cell Head and Neck Cancer 323 345 .
WILLIAM S. BREITBART, WENDY G. LICHTENTHAL, HAYLEY PESSIN & GLORIA C. LEE. 2010. Cancer Pain. Cancer Pain 457 477 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.